Hikma Pharmaceutical | HIK - Ordinary Share Capital


Hikma Pharmaceutical reported $221.89M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Almirall EUR 214.79M 0 Dec/2025
AstraZeneca USD 1.55B 73K Mar/2026
Autolus Therapeutics Ltd USD 266.14M 0 Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Orion EUR 140.87M 173K Mar/2026
Recordati EUR 203.43M 928K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025